Enhancement of lymphokine-activated killer cell activity by fibronectin

被引:5
|
作者
Li, YQ
Kobayashi, M
Kuramitsu, Y
Yuan, L
Matsushita, K
Yagita, H
Okumura, K
Hosokawa, M
机构
[1] HOKKAIDO UNIV,SCH MED,PATHOL LAB,INST CANC,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
[2] JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN
来源
JOURNAL OF IMMUNOTHERAPY | 1997年 / 20卷 / 02期
关键词
lymphokine-activated killer (LAK) activity; extracellular matrix protein; adhesion molecule;
D O I
10.1097/00002371-199703000-00004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we demonstrated that immobilized fibronectin (FN) enhanced lymphokine-activated killer cell (LAK) activity, and that the enhanced LAK activity was completely abrogated by an anti-VLA-5 monoclonal antibody and RGD peptide. Fresh spleen cells expressed VLA-4, VLA-6, and vitronectin receptor, whereas VLA-5 was expressed only on the spleen cells activated with interleukin-2. LAK cells showed increased adhesion to immobilized FN compared with that to control bovine serum albumin, and the increased adhesion of LAK cells to immobilized FN was inhibited by anti-VLA-5 monoclonal antibody. Conjugate-formation assay showed that the LAK cells cultured on immobilized FN bound to target cells more efficiently than the control LAK cells, and that anti-LFA-1 monoclonal antibody inhibited the LAK-target cell binding. Immobilized type IV collagen and laminin, as well as FN, enhanced LAK activity. All of these results suggest that the interaction of integrins expressed on LAK cells with extracellular matrix proteins acts in a costimulatory manner for the enhancement of LAK activity, and that anchorage is necessary for full activation of LAK cells.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [21] NATURAL-KILLER-CELL AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY AGAINST MELANOCYTES IN VITILIGO
    DURHAMPIERRE, DG
    WALTERS, CS
    HALDER, RM
    PHAM, HN
    VANDERPOOL, EA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (01) : 26 - 30
  • [22] HETEROGENEITY OF THE LYMPHOKINE-ACTIVATED KILLER-CELL PHENOTYPE
    CHADWICK, BS
    MILLER, RG
    CELLULAR IMMUNOLOGY, 1991, 132 (01) : 168 - 176
  • [23] Susceptibility of equine chorionic girdle cells to lymphokine-activated killer cell activity
    Vagnoni, KE
    Schram, BR
    Ginther, OJ
    Lunn, DP
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1996, 36 (03) : 184 - 190
  • [24] CYTOSTATIC AND CYTO-TOXIC ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER CELL SUPERNATANTS
    HERSH, EM
    SCUDERI, P
    GRIMES, WJ
    CHONG, A
    BRAILEY, JL
    GSCHWIND, CR
    SALMON, SE
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 30 (01) : 65 - 70
  • [25] GENERATION OF LYMPHOKINE-ACTIVATED KILLER CELL-ACTIVITY FROM HUMAN THYMOCYTES
    RAMSDELL, FJ
    GOLUB, SH
    JOURNAL OF IMMUNOLOGY, 1987, 139 (05): : 1446 - 1453
  • [26] AUGMENTATION OF LYMPHOKINE-ACTIVATED KILLER CELL-ACTIVITY IN PATIENTS WITH GASTROINTESTINAL CANCER
    SEDMAN, PC
    RAMSDEN, CW
    BRENNAN, TG
    GILES, GR
    GUILLOU, PJ
    BRITISH JOURNAL OF SURGERY, 1988, 75 (06) : 591 - 594
  • [27] IMMUNOREGULATION OF LYMPHOKINE-ACTIVATED KILLER CELLS
    NAIR, MPN
    SCHWARTZ, SA
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (01): : 28 - 40
  • [28] Selective antitumor activity of lymphokine-activated killer cells in vitro
    Zhukova, O. S.
    Lebedinskaya, O. V.
    Shubina, I. Zh.
    Gerasimova, G. K.
    Karamin, A. M.
    Kiselevskii, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 143 (01) : 132 - 135
  • [29] CORTICOSTEROIDS INHIBIT THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER ACTIVITY INVITRO
    MCVICAR, DW
    MERCHANT, RE
    MERCHANT, LH
    YOUNG, HF
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 29 (03) : 211 - 218
  • [30] TRANSENDOTHELIAL MIGRATION ACTIVITY OF LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS
    KITAYAMA, J
    JUJI, T
    ATOMI, Y
    KURODA, A
    MUTO, T
    KOBAYASHI, M
    MITSUI, Y
    MINAMI, M
    JOURNAL OF IMMUNOLOGY, 1993, 151 (03): : 1663 - 1672